Clinical Trial Update: Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update describing a Phase 1/2 study of AMT-191 in classic Fabry disease, assessing safety, PK/PD, and exploratory efficacy. Recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• AMT-191

Snippet

Sponsor: UniQure Biopharma B.V. | Conditions: Fabry Disease | Phase 1, Phase 2 | Status: RECRUITING